Abstract:Objective To study the clinical features and gene mutations of early-onset epileptic encephalopathy (EOEE) and to explore the application in pathogenic diagnosis of EOEE by next generation sequencing. Methods The clinical data of 68 cases diagnosed with unexplained EOEE between June 2014 and December 2017 were obtained and analyzed. Specimens were collected from the selected children and their parents. Next generation sequencing was used to detect epilepsy ? related genes, and Sanger sequencing was performed to verify the results and confirm the source of parents, further to identify suspected pathogenic mutations of EOEE. Results Among 68 cases with EOEE, 18 cases (26.47%) were detected with epilepsy?related genes. One was diagnosed as pyridoxine dependent epilepsy (PDE), which was caused by ALDH7A1 mutation. One was diagnosed as thiamine metabolism dysfunction syndrome 2 (THMD2), which was caused by SLC19A3 mutation. Among 13 cases of epilepsy syndrome, 6 cases were diagnosed as Dravet's syndrome (DS), 5 caused by SCN1A missense mutation and one by SCN1A nonsense mutation; 4 cases were diagnosed as infantile spasm (IS), one caused by TSC1 nonsense mutation but the pathogenicity can not be identified while pathogenic mutations were not detected in other 3 cases; 2 cases were diagnosed as Ohtahara's syndrome (OS), one caused by STXBP1 missense mutation and pathogenic mutation was not found in the other; one case of malignant migrating partial seizures in infancy (MMPEI) was not found the pathogenic mutations. Among 53 cases with non-specific EOEE, suspected pathogenic mutations were detected in 9 cases: one case of CN8A missense mutation, one case of KCNQ2 missense mutation, one case of KCNH5 missense mutation, one case of CACNA1A missense mutation, 2 cases of CDKL5 nonsense mutation, one case of CDKL5 frame-shift mutation, one case of PCDH19 nonsense mutation and one case of GRIN2A missense mutation. All cases were treated by 2 and more antiepileptic drugs (AEDs), one case of PDE was given vitamin B6 20 mg/(kg·d), and one case of THMD2 was given vitamin B1 25 mg/(kg·d) and biotin 2 mg/(kg·d). After followed by 6 months to 8 years, 15 cases (22.06%) were seizure free, 21 cases (30.88% ) were part of control and 32 cases (47.06% ) were out of control. Conclusions The clinical phenotypes of children with unexplained EOEE are varied. One case was diagnosed as PDE and one as THMD2 after gene sequencing. After treated by etiological treatment, patients with remediable genetic disease were seizure free. Some gene sites were denovo mutations which have not been reported such as missense mutation for SCN1A, STXBP1, KCNH5, CACNA1A, frame-shift mutation for CDKL5, and onsense mutation for PCDH19, which enriched the mutation spectrum of EOEE. DOI: 10.3969/j.issn.1672-6731.2018.06.008

NGS-Based Identification of Two Novel PCDH19 Mutations in Female Patients with Early-Onset Epilepsy

Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants

Prenatal diagnosis of developmental and epileptic encephalopathy 9 with a 10.05-Mb microdeletion at Xq21.31q22.1 inherited from mother: A case report and literature review

The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population

Multicenter retrospective study of patients with PCDH19‐related epilepsy: The first Hungarian cohort

A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy

Mosaicism and Incomplete Penetrance of PCDH19 Mutations.

[PCDH19 gene mutations lead to epilepsy with mental retardation limited to females in 2 cases and literature review].

[Genotype and Phenotype of Female Dravet Syndrome with PCDH19 Mutations].

Phenotypic and genotypic characteristics of children with PCDH19 clustering epilepsy in China

Dravet-like syndrome with PCDH19 mutations in Taiwan - A multicenter study

Genetic Variants and Phenotype Analysis in a Five-Generation Chinese Pedigree with PCDH19 Female-Limited Epilepsy.

Dissecting the Role of PCDH19 in Clustering Epilepsy by Exploiting Patient-Specific Models of Neurogenesis

Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients

Clinical Characteristics of PCDH19?female Limited Epilepsy

Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel

Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells

PCDH19-related epilepsy in mosaic males: The phenotypic implication of genotype and variant allele frequency

A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity

Clinical Phenotype, Gene Mutation and Application of Targeted Next Generation Sequencing in Patients with Early-Onset Epileptic Encephalopathy

Validation of targeted next-generation sequencing panels in a cohort of polish patients with epilepsy: assessing variable performance across clinical endophenotypes and uncovering novel genetic variants